Hjem › Pankreaskreft › Pennsylvania › Philadelphia
Kliniske studier for Pankreaskreft i Philadelphia, PA
26 studier for Pankreaskreft søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekruttererFase 3
- Thomas Jefferson University, Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Philadelphia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruttererFase 3
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruttererFase 3
- Investigative Site US008, Philadelphia
- Investigative Site US043, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruttererFase 1/2
- Hospital of the University of Pennsylvania, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Rekrutterer
- Fox Chase Cancer Center - Philadelphia, Philadelphia
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekruttererFase 2
- Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office, Philadelphia
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekruttererObservasjonsstudie
- Children's Hospital of Philadelphia, Philadelphia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruttererObservasjonsstudie
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- og 5 flere
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruttererFase 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi unna
- og 1 flere
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Investigative Site #109, Philadelphia
Pancreatic Cancer Early Detection Consortium
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruttererFase 1
- Sidney Kimmel Cancer Center, Philadelphia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekruttererFase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi unna
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi unna
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruttererFase 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Collection of Circulating Biomarkers in Pancreatic Cancer
RekruttererObservasjonsstudie
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RekruttererFase 2
- Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruttererFase 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Pennsylvania, Philadelphia
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruttererFase 2
- Ohio State University-Telemedicine, Philadelphia
- Ohio State University-Telemedicine, Wilmington · 25 mi unna
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
RekruttererObservasjonsstudie
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
FTT PET/CT in Pancreatic Neuroendocrine Tumors
RekruttererFase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RekruttererObservasjonsstudie
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruttererFase 3
- University of Pennsylvania, Philadelphia
Pankreaskreft-studier i andre byer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Tampa, FL26 studier
- Durham, NC24 studier
- San Diego, CA24 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.